MI HB5805

Pharmacists may dispense lower-cost generic equivalents or interchangeable biological products instead of brand-name drugs, or shall do so upon purchaser request, provided a lower-cost option is available.

Prescription labels must indicate both the brand name prescribed and the brand name dispensed, or the generic/proprietary name if no brand name exists.

Pharmacists cannot substitute generics if the prescriber writes "dispense as written" or "d.a.w." on the prescription, or indicates the prescription must be dispensed as communicated.

When substituting an interchangeable biological product, the pharmacist or designee must notify the prescriber within 5 days of the specific product provided, using electronic medical records, pharmacy systems, or other available means.

The Michigan Department of Health must submit annual reports to the legislature beginning June 1, 2018, listing biological drug products added to the FDA's Purple Book and projecting when all therapeutically equivalent products will be included.